This compound is a pharmaceutical intermediate used in the synthesis of Rimegepant. It is a stereochemically defined molecule containing an aromatic heterocyclic ring system.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rimegepant Impurity 73?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
5H-Cyclohepta[b]pyridin-5-amine, 6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-, (5S,6S,9R)-
pharmaceutical intermediate
(3aR,12bR)-5-Chloro-2-methyl-2-oxo-2,3,3a,12b-tetrahydro-1H-2lambda~5~-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
pharmaceutical intermediate
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine
pharmaceutical intermediate
Carbic anhydride
pharmaceutical intermediate
(R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one
research compound
(9R)-6,7,8,9-Tetrahydro-9-hydroxy-5H-cyclohepta[b]pyridin-5-one
research compound
(9S)-9-tri(propan-2-yl)silyloxy-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one
LZTSMPYESKABAS-SFHVURJKSA-N
CC(C)[Si](C(C)C)(C(C)C)O[C@H]1CCCC(=O)C2=C1N=CC=C2
Sourcing Rimegepant Impurity 73?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.